Show simple item record

dc.contributor.authorCrolley, V
dc.contributor.authorRawther, S
dc.contributor.authorChaabouni, N
dc.contributor.authorRigg, A
dc.contributor.authorWadhawan, A
dc.contributor.authorKing, J
dc.date.accessioned2018-02-20T11:41:06Z
dc.date.issued2017-06
dc.identifier.citationClinical Oncology, 2017, 29 (6), pp. e98 - e99
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1386
dc.identifier.doi10.1016/j.clon.2017.01.018
dc.format.extente98 - e99
dc.languageeng
dc.language.isoeng
dc.publisherElsevier BV
dc.titleThe Impact of Oncotype DX Breast Cancer Assay Results on Clinical Practice – a UK Experience
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/j.clon.2017.01.018
rioxxterms.licenseref.startdate2017-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical Oncology
pubs.issue6
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume29en_US
pubs.embargo.termsNot known
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record